LYPLAL1 and Insulin resistance: Although genome-wide identification has shown that genetic variants near LYPLAL1 is associated with insulin resistance, and individuals carrying relative alleles are at higher risk for T2DM [37,38] , these variants falling outside the coding region of LYPLAL1 are unable to explain whether activation or inhibition of LYPLAL1 are linked to T2DM risk.